You just read:

Glenmark Therapeutics Expands Specialty Portfolio With OTIPRIO® Co-Promotion Agreement in the U.S. With Otonomy for Acute Otitis Externa Indication

News provided by

Glenmark Pharmaceuticals Ltd

03 May, 2019, 09:51 IST